Diagnos Laboratorium Utama Tbk. vs Hartadinata Abadi Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Hartadinata Abadi Tbk. trades at Rp1,835 (market cap 8.47T, 13.19M 24h volume). The key difference: Hartadinata Abadi Tbk. is far larger — about 27.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Hartadinata Abadi Tbk. is more actively traded (13.19M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | HRTA | |
|---|---|---|
Market Cap | 310.75B | 8.47T |
Volume | 963.6K | 13.19M |
Lot | 9.64K | 131.91K |
Turnover | 217.67M | 24.2B |
Average Price | 225.89 | 1,834.34 |
Value | 217.67M | 24.2B |
Indicative Equilibrium Price | 226 | 1,835 |
Indicative Equilibrium Volume | 1K | 1.97K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Hartadinata Abadi Tbk (“the Company”) was established based on Notarial Deed No. 11 datedMarch 29, 2004 of Mayasari Soegiharto, S.H.
Read more on HRTA →